Target intelligence / Profile preview

Chemokine-like protein TAFA-2 (TAFA2)

Target
TAFA2
Molecular classification
Secreted protein, Chemokine-like protein, Neurokine, Other
01

Overview

Chemokine-like protein TAFA-2 (TAFA2) is a small secreted protein belonging to the TAFA family, which consists of five highly homologous genes encoding small, brain-predominant proteins with conserved cysteine residues[1]. TAFA2 is distantly related to C-C motif chemokines such as MIP-1α but is more accurately classified as a chemokine-like or neurokine molecule[1][2][7]. It is predominantly expressed in specific brain regions, where it acts as a neurotrophic factor involved in neuronal survival and neurobiological processes[1][2][7]. In addition, TAFA2 has been shown to regulate immune and nervous system cells, suggesting roles in both neurobiology and immune modulation[1][5]. Dysregulation or mutations in TAFA2 have been associated with neuropsychiatric disorders including certain forms of schizophrenia[1]. There is emerging evidence for its involvement in cell migration and recruitment, making it relevant for regenerative medicine contexts[5]. No approved drugs, mechanisms of action, biomarkers, or documented safety concerns specific to TAFA2 have been reported in available sources.

Other names
FAM19A2Chemokine-like protein TAFA-2TAFA chemokine like family member 2TAFA-2Protein FAM19A2Family with sequence similarity 19 member A2C-C motif chemokine-like protein
02

Biological functions

Neuronal survivalNeurobiological functionImmune regulationCellular migration (notably in mesenchymal stem cells)Cell differentiation
03

Disease associations

Neuropsychiatric disease (e.g., schizophrenia)Other (potential roles in nervous and immune system disorders)

Beyond the preview

Go deeper on Chemokine-like protein TAFA-2 (TAFA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chemokine-like protein TAFA-2 (TAFA2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call